Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management

Everolimus-related oral ulcers were frequent and led to dose modifications. Controlled trials, endorsing a consensus in terminology, are needed to evaluate measures on prevention and management of this unique toxicity.